OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
WGRX$0.1156

Wellgistics Health Inc

Advanced Medical Equipment & TechnologyVerified

Wellgistics Health Inc has a negative equity position of $12.45 million and a total debt of $23.49 million, indicating a highly leveraged capital structure. The company's liquidity is constrained, with only $42,570 in cash and equivalents, and a current ratio of 0.09, which is significantly below the industry median. The enterprise value to revenue ratio of 1.6 suggests a low valuation relative to its revenue, but the negative EBITDA and operating cash flow of -$10.86 million highlight ongoing operational challenges. Profitability metrics for Wellgistics Health Inc are concerning, with a net loss of $101.27 million and an operating loss of $96.74 million in the latest period. The return on equity of 8.14% is positive but misleading due to the negative equity base, while the return on assets of -3.32% indicates poor asset utilization. These figures are well below the industry median for profitability, suggesting the company is underperforming its peers. The company's revenue is concentrated in a single business segment, with no disclosed geographic diversification, which increases exposure to regional economic and regulatory risks. There is no information on revenue by geographic region, but the lack of diversification implies a high concentration risk. Looking ahead, the company is projected to continue facing financial challenges, with no clear path to profitability in the near term. The negative operating cash flow and free cash flow of -$98.95 million indicate ongoing cash burn, which could limit the company's ability to invest in growth or service its debt. The company's future performance will depend on its ability to reduce costs, improve operational efficiency, and secure additional financing. The risk assessment for Wellgistics Health Inc highlights significant liquidity and solvency concerns, with a negative net cash position and a debt-to-equity ratio of -1.89. The company's dilution risk is currently low, but the negative equity position and high debt levels could lead to future dilution if the company needs to raise additional capital. The risk of dilution is further compounded by the company's negative net income and operating cash flow, which may necessitate equity financing to fund operations. Recent filings and transcripts indicate that the company is actively seeking ways to improve its financial position, including cost-cutting measures and strategic partnerships. However, the lack of detailed information on these initiatives makes it difficult to assess their potential impact on the company's financial performance. The company's management has acknowledged the challenges and is working to address them, but the path to profitability remains uncertain.

30-day price · WGRX(missing data)
No daily-bar history available from current data sources. Alternate source pending.
Profile
CompanyWellgistics Health Inc
TickerWGRX.O
SectorHealthcare
BusinessHealthcare Services & Equipment
Industry groupHealthcare Services & Equipment
IndustryAdvanced Medical Equipment & Technology
AI analysis

Business. Wellgistics Health Inc provides healthcare equipment and related services, primarily generating revenue through the sale and distribution of medical devices and equipment.

Classification. Wellgistics Health Inc is classified under the Healthcare sector, specifically in the Healthcare Services & Equipment business sector, with a confidence level of 0.92.

Wellgistics Health Inc has a negative equity position of $12.45 million and a total debt of $23.49 million, indicating a highly leveraged capital structure. The company's liquidity is constrained, with only $42,570 in cash and equivalents, and a current ratio of 0.09, which is significantly below the industry median. The enterprise value to revenue ratio of 1.6 suggests a low valuation relative to its revenue, but the negative EBITDA and operating cash flow of -$10.86 million highlight ongoing operational challenges. Profitability metrics for Wellgistics Health Inc are concerning, with a net loss of $101.27 million and an operating loss of $96.74 million in the latest period. The return on equity of 8.14% is positive but misleading due to the negative equity base, while the return on assets of -3.32% indicates poor asset utilization. These figures are well below the industry median for profitability, suggesting the company is underperforming its peers. The company's revenue is concentrated in a single business segment, with no disclosed geographic diversification, which increases exposure to regional economic and regulatory risks. There is no information on revenue by geographic region, but the lack of diversification implies a high concentration risk. Looking ahead, the company is projected to continue facing financial challenges, with no clear path to profitability in the near term. The negative operating cash flow and free cash flow of -$98.95 million indicate ongoing cash burn, which could limit the company's ability to invest in growth or service its debt. The company's future performance will depend on its ability to reduce costs, improve operational efficiency, and secure additional financing. The risk assessment for Wellgistics Health Inc highlights significant liquidity and solvency concerns, with a negative net cash position and a debt-to-equity ratio of -1.89. The company's dilution risk is currently low, but the negative equity position and high debt levels could lead to future dilution if the company needs to raise additional capital. The risk of dilution is further compounded by the company's negative net income and operating cash flow, which may necessitate equity financing to fund operations. Recent filings and transcripts indicate that the company is actively seeking ways to improve its financial position, including cost-cutting measures and strategic partnerships. However, the lack of detailed information on these initiatives makes it difficult to assess their potential impact on the company's financial performance. The company's management has acknowledged the challenges and is working to address them, but the path to profitability remains uncertain.
Key takeaways
  • Wellgistics Health Inc is experiencing significant financial distress, with a net loss of $101.27 million and a negative equity position of $12.45 million.
  • The company's liquidity is severely constrained, with only $42,570 in cash and equivalents and a current ratio of 0.09.
  • Profitability metrics are poor, with a return on assets of -3.32% and a negative operating cash flow of $10.86 million.
  • The company's revenue is concentrated in a single business segment, increasing exposure to regional and regulatory risks.
  • The company is projected to continue facing financial challenges, with no clear path to profitability in the near term.
  • # RATIONALES
  • {
  • "margin_outlook_rationale": "The company's margin outlook is negative due to ongoing operational losses and poor asset utilization.",
Financial snapshot
PeriodHA-latest
CurrencyUSD
Revenue$23.3M
Gross profit-$6.4M
Operating income-$96.7M
Net income-$101.3M
R&D
SG&A
D&A
SBC
Operating cash flow-$10.9M
CapEx-$881.5k
Free cash flow-$98.9M
Total assets$30.5M
Total liabilities$42.9M
Total equity-$12.4M
Cash & equivalents$42.6k
Long-term debt$23.5M
Valuation
Market price$0.11
Market cap$13.8M
Enterprise value$37.3M
P/E
Reported non-GAAP P/E
EV/Revenue1.6
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book-$12.4M
Net cash-$23.4M
Current ratio0.1
Debt/Equity-1.9
ROA-3.3%
ROE8.1%
Cash conversion11.0%
CapEx/Revenue-3.8%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Healthcare Equipment · cohort 91 companies
MetricWGRXActivity
Op margin-414.5%-16.5% medp25 -174.5% · p75 8.8%bottom quartile
Net margin-433.9%-16.5% medp25 -172.4% · p75 8.4%bottom quartile
Gross margin-27.5%47.4% medp25 34.2% · p75 65.3%bottom quartile
CapEx / revenue-3.8%-5.4% medp25 -12.5% · p75 -2.2%above median
Debt / equity-189.0%4.3% medp25 0.0% · p75 28.0%bottom quartile
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod financials
no public URL
2026-05-16 20:06 UTC#bd8313e5
Source: analysis-pipeline (hybrid)Generated: 2026-05-30 00:41 UTCJob: f885dccf